Evaluation of Adherence to Clinical Treatment of Glaucoma
Sponsor
Instituto de Olhos de Goiania (Other)
Overall Status
Unknown status
CT.gov ID
NCT03338088
Collaborator
(none)
150
2
3.9
75
19
Study Details
Study Description
Brief Summary
Evaluation of adherence to clinical treatment of glaucoma in patients of a Reference Ophthalmological Hospital in Goiânia using Morisky Adhesion scale as a validated questionary.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Study Type:
Observational [Patient Registry]
Actual Enrollment
:
150 participants
Observational Model:
Ecologic or Community
Time Perspective:
Other
Official Title:
Evaluation of Adherence to Clinical Treatment of Glaucoma in Patients of a Reference Ophthalmological Hospital in Goiânia
Actual Study Start Date
:
Sep 1, 2017
Actual Primary Completion Date
:
Nov 6, 2017
Anticipated Study Completion Date
:
Dec 30, 2017
Outcome Measures
Primary Outcome Measures
- Evaluation of adherence to clinical treatment of glaucoma in patients of a Reference Ophthalmological Hospital in Goiânia [2 months]
evaluation of the scale
Eligibility Criteria
Criteria
Ages Eligible for Study:
1 Year
to 100 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria: have glaucoma diagnosed -
Exclusion Criteria: not having glaucoma diagnosed
-
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Instituto de Olhos de Goiania | Goiânia | Goias | Brazil | 74110120 |
2 | Instituto de Olhos de Goiania | Goiania | GO | Brazil | 74120-050 |
Sponsors and Collaborators
- Instituto de Olhos de Goiania
Investigators
- Study Director: Joao jr Nassaralla, coordinator, coordinator
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Instituto de Olhos de Goiania
ClinicalTrials.gov Identifier:
NCT03338088
Other Study ID Numbers:
- INSTITUTO DE OLHOS-MAYRA 2018
First Posted:
Nov 9, 2017
Last Update Posted:
Nov 21, 2017
Last Verified:
Nov 1, 2017
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: